

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.23730195 |
| 2 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.14201297 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.01720810 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.57354695 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.57354695 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.51689351 |
| 7 | tolerance induction (GO:0002507) | 5.50851093 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.26210982 |
| 9 | response to interleukin-15 (GO:0070672) | 5.16551229 |
| 10 | negative T cell selection (GO:0043383) | 5.15978288 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 5.06770514 |
| 12 | cellular response to interleukin-15 (GO:0071350) | 5.04882377 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.94157909 |
| 14 | negative thymic T cell selection (GO:0045060) | 4.92031771 |
| 15 | T cell migration (GO:0072678) | 4.80544727 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.61131899 |
| 17 | positive T cell selection (GO:0043368) | 4.55592928 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.52220305 |
| 19 | leukocyte aggregation (GO:0070486) | 4.42794879 |
| 20 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.36392128 |
| 21 | positive thymic T cell selection (GO:0045059) | 4.34675632 |
| 22 | thymic T cell selection (GO:0045061) | 4.09324948 |
| 23 | positive regulation of granulocyte differentiation (GO:0030854) | 4.05494540 |
| 24 | interferon-gamma production (GO:0032609) | 4.01845544 |
| 25 | T cell selection (GO:0045058) | 4.01415302 |
| 26 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.82707153 |
| 27 | mast cell activation (GO:0045576) | 3.78272867 |
| 28 | positive regulation of B cell differentiation (GO:0045579) | 3.76175907 |
| 29 | regulation of B cell differentiation (GO:0045577) | 3.67041531 |
| 30 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.64994432 |
| 31 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.63834819 |
| 32 | B cell receptor signaling pathway (GO:0050853) | 3.60775252 |
| 33 | negative regulation of interleukin-12 production (GO:0032695) | 3.60579932 |
| 34 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.60317693 |
| 35 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.60317693 |
| 36 | T cell receptor signaling pathway (GO:0050852) | 3.59940656 |
| 37 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.58675971 |
| 38 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.54529693 |
| 39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.52838077 |
| 40 | cellular extravasation (GO:0045123) | 3.48253918 |
| 41 | regulation of regulatory T cell differentiation (GO:0045589) | 3.46329848 |
| 42 | dendritic cell chemotaxis (GO:0002407) | 3.43674821 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.43228520 |
| 44 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.42539512 |
| 45 | positive regulation by symbiont of host defense response (GO:0052509) | 3.41701860 |
| 46 | modulation by symbiont of host defense response (GO:0052031) | 3.41701860 |
| 47 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.41701860 |
| 48 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.41701860 |
| 49 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.41701860 |
| 50 | modulation by symbiont of host immune response (GO:0052553) | 3.41701860 |
| 51 | alpha-beta T cell differentiation (GO:0046632) | 3.40251847 |
| 52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.39757995 |
| 53 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.34579271 |
| 54 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.33139000 |
| 55 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.32730848 |
| 56 | regulation of T cell tolerance induction (GO:0002664) | 3.30453134 |
| 57 | activated T cell proliferation (GO:0050798) | 3.29446545 |
| 58 | response to muramyl dipeptide (GO:0032495) | 3.27908758 |
| 59 | NIK/NF-kappaB signaling (GO:0038061) | 3.25789036 |
| 60 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.22584029 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 3.21709365 |
| 62 | type I interferon signaling pathway (GO:0060337) | 3.18906517 |
| 63 | cellular response to type I interferon (GO:0071357) | 3.18906517 |
| 64 | response to type I interferon (GO:0034340) | 3.15093029 |
| 65 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.12782239 |
| 66 | T-helper cell differentiation (GO:0042093) | 3.12649657 |
| 67 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.12649657 |
| 68 | defense response to protozoan (GO:0042832) | 3.12121431 |
| 69 | neutrophil activation (GO:0042119) | 3.11909487 |
| 70 | detection of other organism (GO:0098543) | 3.11683247 |
| 71 | alpha-beta T cell activation (GO:0046631) | 3.11642883 |
| 72 | positive regulation of interleukin-2 production (GO:0032743) | 3.11166501 |
| 73 | detection of bacterium (GO:0016045) | 3.10448334 |
| 74 | regulation of granulocyte differentiation (GO:0030852) | 3.10275136 |
| 75 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.09564222 |
| 76 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.09063653 |
| 77 | negative regulation of bone resorption (GO:0045779) | 3.07558694 |
| 78 | lymphocyte migration (GO:0072676) | 3.05272762 |
| 79 | dendritic cell migration (GO:0036336) | 3.05140809 |
| 80 | regulation of alpha-beta T cell activation (GO:0046634) | 3.04071777 |
| 81 | neutrophil activation involved in immune response (GO:0002283) | 3.03774840 |
| 82 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.03588690 |
| 83 | positive regulation of tolerance induction (GO:0002645) | 3.03276054 |
| 84 | regulation of cell killing (GO:0031341) | 3.03028178 |
| 85 | regulation of tolerance induction (GO:0002643) | 3.02834539 |
| 86 | T cell costimulation (GO:0031295) | 3.00815205 |
| 87 | T cell homeostasis (GO:0043029) | 2.99060550 |
| 88 | response to peptidoglycan (GO:0032494) | 2.97766025 |
| 89 | granulocyte activation (GO:0036230) | 2.97136353 |
| 90 | lymphocyte costimulation (GO:0031294) | 2.96511527 |
| 91 | positive regulation of interleukin-4 production (GO:0032753) | 2.94299550 |
| 92 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.93872998 |
| 93 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.93774696 |
| 94 | Peyers patch development (GO:0048541) | 2.93774696 |
| 95 | lymphocyte chemotaxis (GO:0048247) | 2.90568827 |
| 96 | leukocyte degranulation (GO:0043299) | 2.88829460 |
| 97 | mature B cell differentiation involved in immune response (GO:0002313) | 2.88405576 |
| 98 | T cell differentiation (GO:0030217) | 2.87627959 |
| 99 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.87123842 |
| 100 | positive regulation of cell killing (GO:0031343) | 2.87019492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.72463464 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.65809616 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.65343537 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.00474588 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.73165342 |
| 6 | * MYB_26560356_Chip-Seq_TH2_Human | 3.51567901 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28808247 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.25317692 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.19681878 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.13720330 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.12263560 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.89583056 |
| 13 | MYB_26560356_Chip-Seq_TH1_Human | 2.88560851 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.74606647 |
| 15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.68282164 |
| 16 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.66263817 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.64024926 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.55575636 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.54456538 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.46635773 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39057443 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.36526275 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.31639001 |
| 24 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.30843073 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30014867 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.27223118 |
| 27 | MAF_26560356_Chip-Seq_TH2_Human | 2.20419922 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.14642646 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.14161760 |
| 30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.11779340 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11731517 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.08442982 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03648767 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.02341106 |
| 35 | GATA3_26560356_Chip-Seq_TH2_Human | 1.88830953 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82582332 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75390152 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73443322 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.71143806 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70762125 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70243434 |
| 42 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.67561023 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65678480 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63305822 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57414004 |
| 46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52435223 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52368701 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50647121 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.48919770 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46767590 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41807906 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40557723 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40403095 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40152491 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31006541 |
| 56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29861954 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27322870 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23826870 |
| 59 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.22108364 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21118574 |
| 61 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18407986 |
| 62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16679623 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15607218 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11833253 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11509181 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11224120 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11148003 |
| 68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10020207 |
| 69 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07866875 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07027761 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06618087 |
| 72 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05582618 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05310278 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04895934 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04191114 |
| 76 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03710898 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03616058 |
| 78 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03589624 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00213770 |
| 80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98398935 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98354410 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96094631 |
| 83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95991702 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95074084 |
| 85 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.94324097 |
| 86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94231749 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94101071 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93126954 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92838887 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90048421 |
| 91 | P300_27268052_Chip-Seq_Bcells_Human | 0.90027562 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89769865 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87526159 |
| 94 | GATA3_26560356_Chip-Seq_TH1_Human | 0.86671873 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86440018 |
| 96 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85516236 |
| 97 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84209900 |
| 98 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83742130 |
| 99 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.83283464 |
| 100 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80750853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.15735342 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.04186551 |
| 3 | MP0003436_decreased_susceptibility_to | 3.99480124 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.53248822 |
| 5 | MP0003724_increased_susceptibility_to | 3.44236034 |
| 6 | MP0001800_abnormal_humoral_immune | 3.32132719 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.25006963 |
| 8 | MP0002723_abnormal_immune_serum | 2.89731438 |
| 9 | MP0009785_altered_susceptibility_to | 2.81326582 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.77595234 |
| 11 | MP0005025_abnormal_response_to | 2.77561950 |
| 12 | MP0001790_abnormal_immune_system | 2.75920850 |
| 13 | MP0005387_immune_system_phenotype | 2.75920850 |
| 14 | MP0000685_abnormal_immune_system | 2.74951683 |
| 15 | MP0001819_abnormal_immune_cell | 2.74206628 |
| 16 | MP0003303_peritoneal_inflammation | 2.70158157 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.63715320 |
| 18 | MP0002419_abnormal_innate_immunity | 2.54974290 |
| 19 | MP0009333_abnormal_splenocyte_physiolog | 2.53163784 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.50254393 |
| 21 | MP0002398_abnormal_bone_marrow | 2.43247740 |
| 22 | MP0000716_abnormal_immune_system | 2.24277341 |
| 23 | MP0000703_abnormal_thymus_morphology | 2.23627429 |
| 24 | MP0010155_abnormal_intestine_physiology | 2.19450684 |
| 25 | MP0003866_abnormal_defecation | 2.14169264 |
| 26 | MP0002405_respiratory_system_inflammati | 2.11082891 |
| 27 | MP0004381_abnormal_hair_follicle | 2.03947622 |
| 28 | MP0002722_abnormal_immune_system | 2.03121341 |
| 29 | MP0003300_gastrointestinal_ulcer | 2.02351322 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.97156254 |
| 31 | MP0006082_CNS_inflammation | 1.94123309 |
| 32 | MP0001873_stomach_inflammation | 1.90301835 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.88018775 |
| 34 | MP0004947_skin_inflammation | 1.81765897 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.76831045 |
| 36 | MP0002429_abnormal_blood_cell | 1.76167442 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.70994774 |
| 38 | MP0005310_abnormal_salivary_gland | 1.63255967 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.61853079 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.52863281 |
| 41 | MP0009278_abnormal_bone_marrow | 1.49560403 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.46145984 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.42558626 |
| 44 | MP0009764_decreased_sensitivity_to | 1.41324870 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.40218066 |
| 46 | MP0008469_abnormal_protein_level | 1.32798542 |
| 47 | MP0002933_joint_inflammation | 1.31599243 |
| 48 | MP0002009_preneoplasia | 1.30848351 |
| 49 | MP0002132_abnormal_respiratory_system | 1.24114152 |
| 50 | MP0005377_hearing/vestibular/ear_phenot | 1.20916789 |
| 51 | MP0003878_abnormal_ear_physiology | 1.20916789 |
| 52 | MP0001853_heart_inflammation | 1.18894445 |
| 53 | MP0002006_tumorigenesis | 1.14303532 |
| 54 | MP0001851_eye_inflammation | 1.10468905 |
| 55 | MP0003448_altered_tumor_morphology | 1.06140289 |
| 56 | MP0000858_altered_metastatic_potential | 1.06099060 |
| 57 | MP0008004_abnormal_stomach_pH | 1.03865940 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.01200042 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 0.97392788 |
| 60 | MP0008057_abnormal_DNA_replication | 0.96904517 |
| 61 | MP0008260_abnormal_autophagy | 0.96840149 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 0.95888458 |
| 63 | MP0002998_abnormal_bone_remodeling | 0.94537799 |
| 64 | MP0001545_abnormal_hematopoietic_system | 0.93282702 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 0.93282702 |
| 66 | MP0003172_abnormal_lysosome_physiology | 0.92873856 |
| 67 | MP0005451_abnormal_body_composition | 0.92670418 |
| 68 | MP0005410_abnormal_fertilization | 0.92009188 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 0.91506805 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 0.88418523 |
| 71 | MP0004883_abnormal_blood_vessel | 0.88021488 |
| 72 | MP0001986_abnormal_taste_sensitivity | 0.83275118 |
| 73 | MP0005166_decreased_susceptibility_to | 0.81192546 |
| 74 | MP0001348_abnormal_lacrimal_gland | 0.80489269 |
| 75 | MP0000490_abnormal_crypts_of | 0.78477073 |
| 76 | MP0001663_abnormal_digestive_system | 0.78106663 |
| 77 | MP0003045_fibrosis | 0.75634160 |
| 78 | MP0002019_abnormal_tumor_incidence | 0.75344245 |
| 79 | MP0004510_myositis | 0.72149622 |
| 80 | MP0009763_increased_sensitivity_to | 0.71261248 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.70093355 |
| 82 | MP0003828_pulmonary_edema | 0.69630315 |
| 83 | MP0000604_amyloidosis | 0.69575625 |
| 84 | MP0005390_skeleton_phenotype | 0.68011882 |
| 85 | MP0002163_abnormal_gland_morphology | 0.66854817 |
| 86 | MP0001764_abnormal_homeostasis | 0.65738869 |
| 87 | MP0002693_abnormal_pancreas_physiology | 0.64499237 |
| 88 | MP0003646_muscle_fatigue | 0.62808012 |
| 89 | MP0005164_abnormal_response_to | 0.60946200 |
| 90 | MP0002638_abnormal_pupillary_reflex | 0.60374393 |
| 91 | MP0001919_abnormal_reproductive_system | 0.58346457 |
| 92 | MP0004130_abnormal_muscle_cell | 0.58223341 |
| 93 | MP0000249_abnormal_blood_vessel | 0.56122637 |
| 94 | MP0008873_increased_physiological_sensi | 0.55143527 |
| 95 | MP0001501_abnormal_sleep_pattern | 0.51246780 |
| 96 | MP0000372_irregular_coat_pigmentation | 0.50783985 |
| 97 | MP0003795_abnormal_bone_structure | 0.50356023 |
| 98 | MP0005376_homeostasis/metabolism_phenot | 0.48481130 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.47836547 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.46999997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.99982332 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.74389281 |
| 3 | Stomatitis (HP:0010280) | 5.44294870 |
| 4 | T lymphocytopenia (HP:0005403) | 5.30409219 |
| 5 | Abnormality of T cell number (HP:0011839) | 4.98393202 |
| 6 | Myositis (HP:0100614) | 4.83588341 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.77730184 |
| 8 | Abnormality of T cells (HP:0002843) | 4.56095431 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.50109134 |
| 10 | IgG deficiency (HP:0004315) | 4.44390327 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 4.37725147 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.18938747 |
| 13 | Optic neuritis (HP:0100653) | 4.18938747 |
| 14 | Orchitis (HP:0100796) | 4.06953895 |
| 15 | Autoimmune hemolytic anemia (HP:0001890) | 4.05124740 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 4.04370580 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.04370580 |
| 18 | Severe combined immunodeficiency (HP:0004430) | 4.02091245 |
| 19 | Meningitis (HP:0001287) | 3.95373381 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.89166578 |
| 21 | Abnormality of T cell physiology (HP:0011840) | 3.86890066 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.86781109 |
| 23 | Encephalitis (HP:0002383) | 3.76206947 |
| 24 | Increased IgM level (HP:0003496) | 3.68124651 |
| 25 | Recurrent viral infections (HP:0004429) | 3.66445470 |
| 26 | Obstructive lung disease (HP:0006536) | 3.66013864 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.66013864 |
| 28 | B lymphocytopenia (HP:0010976) | 3.63766765 |
| 29 | Abnormality of B cell number (HP:0010975) | 3.61947543 |
| 30 | Agammaglobulinemia (HP:0004432) | 3.60537685 |
| 31 | Pustule (HP:0200039) | 3.59516005 |
| 32 | Vasculitis (HP:0002633) | 3.57446641 |
| 33 | Abnormality of macrophages (HP:0004311) | 3.54132403 |
| 34 | Increased IgE level (HP:0003212) | 3.53331457 |
| 35 | IgM deficiency (HP:0002850) | 3.45470686 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 3.42398227 |
| 37 | Leukocytosis (HP:0001974) | 3.41021361 |
| 38 | Granulocytopenia (HP:0001913) | 3.39610747 |
| 39 | Recurrent bronchitis (HP:0002837) | 3.37946005 |
| 40 | Eosinophilia (HP:0001880) | 3.32998257 |
| 41 | Abnormality of eosinophils (HP:0001879) | 3.32805254 |
| 42 | Combined immunodeficiency (HP:0005387) | 3.25624790 |
| 43 | Lymphopenia (HP:0001888) | 3.19180131 |
| 44 | Recurrent skin infections (HP:0001581) | 3.17829012 |
| 45 | Keratoconjunctivitis sicca (HP:0001097) | 3.12452561 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 3.10723106 |
| 47 | Spontaneous hematomas (HP:0007420) | 3.03443496 |
| 48 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.98898061 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.92748230 |
| 50 | Chest pain (HP:0100749) | 2.91688953 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.89664168 |
| 52 | Hemoptysis (HP:0002105) | 2.86834595 |
| 53 | Chronic diarrhea (HP:0002028) | 2.86008938 |
| 54 | Autoimmune thrombocytopenia (HP:0001973) | 2.82670268 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.73346130 |
| 56 | Hypergammaglobulinemia (HP:0010702) | 2.67417866 |
| 57 | Inflammation of the large intestine (HP:0002037) | 2.66803737 |
| 58 | Hypoplasia of the thymus (HP:0000778) | 2.58739436 |
| 59 | Papilloma (HP:0012740) | 2.57752948 |
| 60 | Verrucae (HP:0200043) | 2.57752948 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.57294698 |
| 62 | Thyroiditis (HP:0100646) | 2.56162388 |
| 63 | Joint swelling (HP:0001386) | 2.53421293 |
| 64 | Abnormality of the prostate (HP:0008775) | 2.52214594 |
| 65 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49737694 |
| 66 | Gingivitis (HP:0000230) | 2.49707660 |
| 67 | Recurrent sinusitis (HP:0011108) | 2.49340938 |
| 68 | Hypochromic anemia (HP:0001931) | 2.45766675 |
| 69 | Stomach cancer (HP:0012126) | 2.41734631 |
| 70 | Lymphoma (HP:0002665) | 2.40547373 |
| 71 | Colitis (HP:0002583) | 2.40483680 |
| 72 | Pulmonary embolism (HP:0002204) | 2.34597010 |
| 73 | Cellulitis (HP:0100658) | 2.34341754 |
| 74 | Acute hepatic failure (HP:0006554) | 2.33920285 |
| 75 | Seborrheic dermatitis (HP:0001051) | 2.33814547 |
| 76 | Abnormality of the fingertips (HP:0001211) | 2.31818649 |
| 77 | Gastrointestinal stroma tumor (HP:0100723) | 2.30198326 |
| 78 | Hypochromic microcytic anemia (HP:0004840) | 2.30084317 |
| 79 | Arterial thrombosis (HP:0004420) | 2.27928725 |
| 80 | Basal cell carcinoma (HP:0002671) | 2.26499978 |
| 81 | Prostate neoplasm (HP:0100787) | 2.26086528 |
| 82 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.25336530 |
| 83 | Urticaria (HP:0001025) | 2.24818830 |
| 84 | IgA deficiency (HP:0002720) | 2.22321478 |
| 85 | Epistaxis (HP:0000421) | 2.21875550 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.17878603 |
| 87 | Episodic fever (HP:0001954) | 2.17380769 |
| 88 | Gangrene (HP:0100758) | 2.17374485 |
| 89 | Sepsis (HP:0100806) | 2.15420772 |
| 90 | Anorexia (HP:0002039) | 2.14234524 |
| 91 | Slow saccadic eye movements (HP:0000514) | 2.13247071 |
| 92 | Osteomyelitis (HP:0002754) | 2.12593755 |
| 93 | Papilledema (HP:0001085) | 2.11290388 |
| 94 | Bronchitis (HP:0012387) | 2.07259902 |
| 95 | Glomerulopathy (HP:0100820) | 1.95724426 |
| 96 | Keratitis (HP:0000491) | 1.95485538 |
| 97 | Acne (HP:0001061) | 1.93224547 |
| 98 | Microcytic anemia (HP:0001935) | 1.90953206 |
| 99 | Abnormality of the columella (HP:0009929) | 1.90299651 |
| 100 | Skin rash (HP:0000988) | 1.90299363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.18847054 |
| 2 | MAP4K1 | 4.69967513 |
| 3 | RIPK4 | 3.89052824 |
| 4 | SIK3 | 2.75504295 |
| 5 | TAOK3 | 2.52439964 |
| 6 | GRK6 | 2.46932806 |
| 7 | IRAK4 | 2.31082458 |
| 8 | TYK2 | 2.18834264 |
| 9 | BTK | 2.17766837 |
| 10 | MAP3K13 | 2.17669468 |
| 11 | ITK | 2.16820893 |
| 12 | ZAP70 | 2.11857158 |
| 13 | SIK2 | 2.10522309 |
| 14 | FES | 1.93932575 |
| 15 | NLK | 1.93304109 |
| 16 | PRPF4B | 1.86742332 |
| 17 | BLK | 1.84540227 |
| 18 | JAK3 | 1.84431359 |
| 19 | CSK | 1.82818624 |
| 20 | PASK | 1.82003188 |
| 21 | IKBKE | 1.81973467 |
| 22 | TEC | 1.78413865 |
| 23 | MAP3K14 | 1.78328732 |
| 24 | SYK | 1.72156593 |
| 25 | TNK2 | 1.66070063 |
| 26 | MARK3 | 1.62630563 |
| 27 | IKBKB | 1.52847682 |
| 28 | LCK | 1.51090563 |
| 29 | HCK | 1.50554343 |
| 30 | TBK1 | 1.41119729 |
| 31 | MAP3K11 | 1.38093021 |
| 32 | JAK1 | 1.33086887 |
| 33 | LYN | 1.31566828 |
| 34 | BMPR2 | 1.27225110 |
| 35 | EPHB1 | 1.26492777 |
| 36 | TESK2 | 1.21801323 |
| 37 | SIK1 | 1.15111991 |
| 38 | MAP2K3 | 1.14569636 |
| 39 | JAK2 | 1.12923032 |
| 40 | MAP4K2 | 1.07848149 |
| 41 | BRD4 | 1.07063753 |
| 42 | ERN1 | 1.00316751 |
| 43 | CAMKK1 | 0.97264149 |
| 44 | MAP3K1 | 0.92231181 |
| 45 | IRAK1 | 0.91515463 |
| 46 | KDR | 0.88611520 |
| 47 | CDK12 | 0.88548704 |
| 48 | GRK7 | 0.87851331 |
| 49 | PIM1 | 0.87435664 |
| 50 | PRKCQ | 0.85223252 |
| 51 | FGFR4 | 0.83894083 |
| 52 | MAP3K10 | 0.82284115 |
| 53 | KIT | 0.81544706 |
| 54 | PDK1 | 0.81410945 |
| 55 | CSF1R | 0.80697535 |
| 56 | MAP3K7 | 0.80354921 |
| 57 | HIPK2 | 0.80066288 |
| 58 | PIK3CG | 0.77004677 |
| 59 | MATK | 0.75210403 |
| 60 | MARK2 | 0.73695003 |
| 61 | FGFR3 | 0.72574802 |
| 62 | CDK4 | 0.72293387 |
| 63 | STK10 | 0.68908461 |
| 64 | MAP2K2 | 0.67647254 |
| 65 | CAMKK2 | 0.58024284 |
| 66 | KSR2 | 0.57562016 |
| 67 | EPHA3 | 0.57153659 |
| 68 | CHUK | 0.55552648 |
| 69 | DYRK1B | 0.52617635 |
| 70 | FYN | 0.51623480 |
| 71 | MAP3K3 | 0.51265409 |
| 72 | FGR | 0.51034592 |
| 73 | MAPK7 | 0.49791668 |
| 74 | SMG1 | 0.47685003 |
| 75 | CLK1 | 0.46200836 |
| 76 | RPS6KC1 | 0.45754854 |
| 77 | RPS6KL1 | 0.45754854 |
| 78 | RPS6KA6 | 0.43887617 |
| 79 | CDK6 | 0.43453580 |
| 80 | ADRBK2 | 0.43281691 |
| 81 | PIK3CA | 0.40966771 |
| 82 | MAPK11 | 0.39250850 |
| 83 | MAPK12 | 0.39029293 |
| 84 | IRAK2 | 0.38634075 |
| 85 | YES1 | 0.38413525 |
| 86 | WNK1 | 0.37743820 |
| 87 | STK38 | 0.37609142 |
| 88 | PRKCH | 0.36933217 |
| 89 | PTK6 | 0.36083751 |
| 90 | MAP2K6 | 0.35954550 |
| 91 | CAMK4 | 0.35356689 |
| 92 | RIPK1 | 0.35120872 |
| 93 | PDPK1 | 0.34974065 |
| 94 | CDK19 | 0.32684807 |
| 95 | TAOK1 | 0.30916686 |
| 96 | UHMK1 | 0.30336051 |
| 97 | MAPKAPK2 | 0.28559576 |
| 98 | RET | 0.26205900 |
| 99 | STK11 | 0.24259574 |
| 100 | NEK6 | 0.24099636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.32480331 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.06715539 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.06404722 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.91538186 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.78420218 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.67652672 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.43118501 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.36629116 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.36462515 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.32765706 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.30107267 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.29459936 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.27707915 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.24575335 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.09597881 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.94457380 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.93621437 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.91022461 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.83401195 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74412031 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68332608 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68328000 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61296027 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60123006 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.54752232 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54626724 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.53277588 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.50470331 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.48082358 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.46400376 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43238378 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43118755 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41372925 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33030864 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.25570134 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24101442 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.15777384 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12537361 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11348679 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.04000901 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99157260 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95574851 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 0.89317634 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88322381 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87066843 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 0.85237429 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82276645 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82046769 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.81567700 |
| 50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81309921 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80888572 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80627626 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.76672417 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75834134 |
| 55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75735502 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72085156 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69613378 |
| 58 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66034794 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63233559 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63140918 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62996054 |
| 62 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62973422 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62683999 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.62246338 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59461484 |
| 66 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56687237 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55989628 |
| 68 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55428212 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52881880 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51003152 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50369478 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50265717 |
| 73 | Salmonella infection_Homo sapiens_hsa05132 | 0.49256991 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48064000 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47265086 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46241644 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.45904766 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45307069 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.44310823 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41318335 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.40875594 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40101535 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39789945 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38516762 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.37522660 |
| 86 | Thyroid cancer_Homo sapiens_hsa05216 | 0.35847290 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34391188 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.32455948 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29590925 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28024440 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24982928 |
| 92 | Ribosome_Homo sapiens_hsa03010 | 0.23003171 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.22764406 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22404222 |
| 95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.21221797 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.20970294 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.19291998 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.18805037 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18508484 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.18504817 |

